Repligen
RGEN
#2045
Rank
ยฃ6.97 B
Marketcap
ยฃ123.84
Share price
-0.47%
Change (1 day)
11.07%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): ยฃ17.71 Million

According to Repligen 's latest financial reports the company's current earnings are ยฃ0.70 Billion. In 2024 the company made an earning of -ยฃ4.74 Million a decrease over its 2023 earnings that were of ยฃ36.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ17.71 M-474.44%
2024 -ยฃ4.74 Million-113.01%
2023 ยฃ36.36 M-78.01%
2022 ยฃ0.16 B33.37%
2021 ยฃ0.12 B131.52%
2020 ยฃ53.55 M101.31%
2019 ยฃ26.6 M25.93%
2018 ยฃ21.12 M105.61%
2017 ยฃ10.27 M-11.46%
2016 ยฃ11.6 M14.91%
2015 ยฃ10.09 M20.26%
2014 ยฃ8.39 M-51.49%
2013 ยฃ17.31 M90.98%
2012 ยฃ9.06 M
2010 ยฃ0.13 M-103.81%
2009 -ยฃ3.45 Million-223.84%
2008 ยฃ2.78 M
2006 -ยฃ1.87 Million229.64%
2005 -ยฃ0.57 Million-89.16%
2004 -ยฃ5.23 Million-16.86%
2003 -ยฃ6.29 Million88.72%
2002 -ยฃ3.34 Million-27.88%
2001 -ยฃ4.63 Million-1.74%
2000 -ยฃ4.71 Million85.93%
1999 -ยฃ2.53 Million159.16%
1998 -ยฃ0.98 Million85.71%
1997 -ยฃ0.53 Million-70.83%
1996 -ยฃ1.81 Million-72.41%
1995 -ยฃ6.54 Million-60.63%
1994 -ยฃ16.59 Million45.39%
1993 -ยฃ11.41 Million39.45%
1992 -ยฃ8.19 Million-32.3%
1991 -ยฃ12.09 Million6.62%
1990 -ยฃ11.34 Million1577.78%
1989 -ยฃ0.68 Million-57.14%
1988 -ยฃ1.58 Million-362.5%
1987 ยฃ0.6 M-130.77%
1986 -ยฃ1.96 Million136.36%
1985 -ยฃ0.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
ยฃ0.28 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.50 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.43 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ7.70 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ5.32 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.02 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.89 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ86.73 M 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ81.85 Million-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-ยฃ16.67 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA